Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 8-K Event Results of operations
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 10-K Report Annual Report
  6. 4 Planned sale Chief Scientific Officer sold 2,598 shares at $13.95 ($36,242)
  7. 4 Planned sale SVP, Head of Finance & Admin. sold 2,488 shares at $13.95 ($34,708)
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 4 Grant or award Director acquired 1,111,111 shares (grant or award)
  15. 8-K Event Results of operations · Regulation FD disclosure · Other events
  16. 4 Planned sale Chief Scientific Officer sold 2,334 shares at $28.12 ($65,632)
  17. 4 Planned sale SVP, Head of Finance & Admin. sold 1,455 shares at $28.12 ($40,915)
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 14 of 40 · 796 filings